Market View 28th June 2022

View on market: Stay Cautious, be with quality business:

Stocks in Asia are off to a soft start on Tuesday amid a rise in crude oil prices and US Treasury yields. Equities rose in Japan, South Korea and Australia after US futures were volatile following losses for S&P 500 and Nasdaq 100. As of 7:40 am, the Singapore-traded SGX Nifty–an early barometer of India’s benchmark Nifty 50–fell 0.35% to 15,778. The dollar was little changed while crude rose toward $110 a barrel. This rise in crude prices comes even as Libya and Ecuador flagged potential output cuts on political unrest.

Economic Calendar:

• INR: M3 Money Supply29th June
• INR: Fiscal Deficit Data 30^th June 2022.
• USD: API Weekly Crude Oil Supply 29^th June, 2022.
• USD: Mortgage Market Index 29^th June, 2022.

Brokerage Radar:

UBS ON M&M: Buy, TP Rs 1250 With Scorpio-N,ride quality, handling, design & features have been significantly enhanced Given expected success of Scorpio-N, strong order backlogs for XUV700, Thar & ramp in production, see upside risk to FY24E vol assumption.

KOTAK INST ON UJJIVAN SMALL FINANCE BANK: Upgrade to buy, TP Rs 20 Discussions with management indicate growth appetite is back, especially in microfinance bk along with recovery in credit demand from select segments Expect stability in top management team going forward

MORGAN STANLEY ON BAJAJ AUTO:EW, TP Rs 4182 Assuming buy-back happens at maximum price, co will buyback 5.4 m sh No of shares could, however, be higher if buyback price is lower than maximum limit Out of total outlay, co will utilize at least 50% of amount (Rs12.5 bn).

UBS ON BAJAJ AUTO: Neutral, TP Rs 3800 Open market buy-back up to Rs25bn Buy-back size- c13% of surplus cash & c9% of share capital + reserves CMP, reduction in total paid-up share capital will be 2.2%, assuming maximum buy-back of Rs25bn

MORGAN STANLEY ON M&M: OW, TP Rs 1198 Launch – Scorpio-N Multiple new launches in SUV segment underscore SUV focus of OEMs & also point towards easing supply chain issues Believe PVs will continue to lead recovery in autos

International Markets:

U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DII:

News Update:

Aurobindo Pharma: SEBI has warned the drugmaker for not meeting its disclosure requirements by not providing full details related to observations by the the US Food and Drug Administration.

Cipla: The company will invest Rs 25.9 crore in associate firm GoApptiv increasing its stake to 22.02%. The investment will enable wider reach of the Cipla’s key brands in Tier-3+ towns through GoApptiv’s solutions.

Star Health/IDFC First: The companies have entered into a strategic partnership where Star Health will offer its health insurance products to the bank’s customers using bank’s digital platform and distribution network.

Bank of Baroda: The state-run lender has announced plans to raise long term bonds worth Rs 5,000 crore in FY23.

Mahindra & Mahindra: The company has unveiled new car model name Scorpio-N; prices Scorpio-N SUV starting at Rs 11.9 lakh.

Manappuram Finance: The company will consider $100 million bond issuance on Thursday.

Hindustan Aeronautics: The company’s board will consider the recommendation of final dividend.

Route Mobile: The company will consider proposal of shares buyback today.

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL